CIMT meets SFIT 2007, Hofstuben Convention Center at Fortress Marienburg (Wuerzburg, Germany)
2007-04-12 to 2007-04-14
Day 1 (12th April 2007)
8:30-8:45 Welcoming Address Keynote Lectures
08:45-09:30
Harald zur Hausen (Heidelberg)
Infections and cancer: novel modes of cancer prevention 09:30-10:15
Fritz Melchers (Basel)
Bone marrow transplantation revised
10:15-10:45
Coffee Break
Session 1:
Defenses against Infectious Pathogens
10:45-11:25
Tom Aebischer (Edinburgh)
Helicobacter pylori: An update on vaccine development and correlates of immunity 11:25-12:05
Antonio Coutinho (Oeiras)
To be announced 12:05-12:45
Gillis R. Otten (Emeryville)
To be announced
13:00-14:15
Lunch Break
Poster Session I
14:15-15:45
Guided Poster Session & Coffee
Session 2:
Biotech boosts Tumorimmunology 16:00-16:30
Özlem Türeci (Ganymed, Mainz)
Novel antibody therapeutics for solid cancers 16:30-17:00
Marlies Sproll (Morphosys, Martinsried)
Human monoclonal antibodies for therapy 17:00-17:30
Mark Krul (Isa Pharmaceuticals, Leiden)
The benefits of biomedical venturing
Day 2 (13th April 2007) Session 3:
Tumor Vaccines 08:30-09:10
Hans-Georg Rammensee (Tübingen)
Tumor-associated peptides for individualized vaccination 09:10-09:50
Christian Ottensmeier (Southampton)
DNA fusion vaccines against prostate cancer: from the bench to the bedside 09:50-10:30
Pramod Srivastava (Farmington)
gp96-peptide complexes for immunotherapy of stage IV melanoma and adjuvant renal cell carcinoma 10:30-11:00
Coffee Break 11:00-11:40
Yvonne Paterson (Philadelphia)
Listeria based vaccines for breast and cervical cancer Session 4:
Effector Mechanisms in Antibody Based Cancer Therapy 11:40-12:20
Jeffrey V. Ravetch (New York)
Antibodies and their receptors: linking innate and adaptive immunity 12:20-13:00
George Weiner (Iowa City)
Complement and cellular cytotoxicity in antibody therapy of cancer 13:00-14:00
Lunch Break Poster Session II
14:00-15:30
Guided Poster Session & Coffee
Session 4 (cont.): Effector Mechanisms in Antibody Based Cancer Therapy 15:30-16:10
Dario Neri (Zurich)
Antibody-based vascular tumor targeting: from the bench to the clinic 16:10-16:50
Manuel L. Penichet (Los Angeles)
Antibody-cytokine fusion proteins: applications in cancer therapy Session 5:
Development of Immunity 16:50-17:30
Harald von Boehmer (Boston)
Foxp3 positive Treg: generation, lifestyle and function
20:00 Dinner at ”Fürstensaal Residenz Würzburg”
Day 3 (14th April 2007)
Session 5 (cont.):
Development of Immunity
8:30-9:10
Bruno Kyewski (Heidelberg)
How promiscuity promotes tolerance 9:10-9:50
Sjoerd H. van der Burg (Leiden)
Tumor-specific T-regulatory cells in tumor-specific vaccination strategies 9:50-10:30
Thomas Boehm (Freiburg)
Quality strategies in self/non-self discrimination
10:30-11:00
Coffee Break
Session 6:
Host-pathogen Interactions
11:00-11:40
Jörg Hacker (Würzburg) Host - microbe interactions in the gastrointestinal tract:
Escherichia coli as an example 11:40-12:30
Vincenzo Bronte (Padua)
Myeloid-derived suppressor cells in cancer:
a novel target for therapeutic invention 12:30-13:10
Emmanuel Lemichez (Nice)
Uropathogenic E. coli CNF1 toxin molecular mechanism of action and application in vaccinology
13:10-13:50
Dirk Bumann (Hannover)
System-level analysis of Salmonella-host interactions
13:50-14:30
Lunch Break Satellite Session:
CIMT Monitoring Panel 14:30 – 15:00:
Andreas Thiel (Berlin)
Direct access to CD4 T cells specific for defined antigens according to CD154 expression 15:00 – 15:30:
Helmut M. Diepolder (Munich)
HLA class II tetramers for enumeration and phenotyping of hepatitis C virus specific CD4+ T cells 15:30 – 16:00:
Cedrik M. Britten (Leiden)
Lessons learned from interlaboratory testing in phases I/2005 and II/2006” 16:00 – 16:15:
Announcement of new panel activities and inter-laboratory testing projects
16:15 – 16:45
Round table discussion
|